BioGaia AB (publ)
BioGaia AB (publ) Fundamental Analysis
BioGaia AB (publ) (BIOGY) shows moderate financial fundamentals with a PE ratio of 30.35, profit margin of 21.64%, and ROE of 24.30%. The company generates $1.5B in annual revenue with moderate year-over-year growth of 9.73%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 79.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze BIOGY's fundamental strength across five key dimensions:
Efficiency Score
ExcellentBIOGY demonstrates superior asset utilization.
Valuation Score
ModerateBIOGY shows balanced valuation metrics.
Growth Score
ModerateBIOGY shows steady but slowing expansion.
Financial Health Score
ExcellentBIOGY maintains a strong and stable balance sheet.
Profitability Score
ExcellentBIOGY achieves industry-leading margins.
Key Financial Metrics
Is BIOGY Expensive or Cheap?
P/E Ratio
BIOGY trades at 30.35 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, BIOGY's PEG of 0.61 indicates potential undervaluation.
Price to Book
The market values BioGaia AB (publ) at 7.66 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 23.42 times EBITDA. This signals the market has high growth expectations.
How Well Does BIOGY Make Money?
Net Profit Margin
For every $100 in sales, BioGaia AB (publ) keeps $21.64 as profit after all expenses.
Operating Margin
Core operations generate 27.07 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $24.30 in profit for every $100 of shareholder equity.
ROA
BioGaia AB (publ) generates $20.77 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
BioGaia AB (publ) produces operating cash flow of $296.08M, showing steady but balanced cash generation.
Free Cash Flow
BioGaia AB (publ) generates strong free cash flow of $292.58M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $2.97 in free cash annually.
FCF Yield
BIOGY converts 3.07% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
30.35
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.61
vs 25 benchmark
P/B Ratio
Price to book value ratio
7.66
vs 25 benchmark
P/S Ratio
Price to sales ratio
6.39
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
6.12
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.24
vs 25 benchmark
ROA
Return on assets percentage
0.21
vs 25 benchmark
ROCE
Return on capital employed
0.30
vs 25 benchmark
How BIOGY Stacks Against Its Sector Peers
| Metric | BIOGY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 30.35 | 29.78 | Neutral |
| ROE | 24.30% | 792.00% | Weak |
| Net Margin | 21.64% | -23280.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.25 | Strong (Low Leverage) |
| Current Ratio | 6.12 | 4.60 | Strong Liquidity |
| ROA | 20.77% | -18077.00% (disorted) | Strong |
BIOGY outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews BioGaia AB (publ)'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
58.80%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
60.86%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
116.48%
Industry Style: Defensive, Growth, Innovation
High Growth